A poor prognosis has been linked to HLA-E expression in various malignancies including colorectal cancer, gastric cancer, gynecological cancers, non-small cell lung cancer (NSCLC) and breast cancer (11–16). This evidence concerns the gene HLA-E and non-small cell lung carcinoma.